CURE Magazine Joins US Oncology

DALLAS, Feb. 17 /PRNewswire/ -- CURE Media Group, publisher of the award-winning CURE magazine, is pleased to announce that it has joined US Oncology, Inc., the nation's premier community oncology services company working with more than 1,300 physicians and more than 10,000 clinicians and cancer experts to advance cancer care in America. CURE, the largest magazine in the country for people with cancer, is the nation's trusted source for cancer patient education and will continue its mission of providing patients and survivors the highest quality cancer information.

"CURE's primary objective is, and always has been, to deliver top-notch cancer information to patients, survivors, and their caregivers at precisely the right time and place," says CURE publisher and cancer survivor Susan McClure. "This new association with US Oncology will help us ensure that even more patients across the country have immediate access to the credible cancer information they need, written in terms they can understand."

Joining the US Oncology family allows CURE to expand its reach to the more than 720,000 cancer patients treated within the US Oncology network, and provides the CURE team with the resources to continue serving the individuals, hospitals, cancer centers, and nonprofits that comprise its 325,000 other national subscribers.

Led by McClure and fellow cancer survivor and editor-at-large Kathy LaTour, CURE maintains its commitment to journalistic independence and high editorial standards. Having received 30 national awards in the seven years since its launch, CURE's pledge to providing patients with timely, up-to-date, and credible information about treatment options, side effects, and psychosocial issues, will remain intact and become more robust thanks to expanded access to nationally renowned oncologists and thought leaders within the US Oncology network.

"The US Oncology operating model ensures independence and entrepreneurship with its affiliations, as evidenced by the company's relationship with iKnowMed™, AccessMED™, and its affiliated oncology practices. Our role with CURE is to provide the magazine with the means to continue as the trusted information source for newly diagnosed cancer patients, and to increase public access to CURE's patient education so that every newly diagnosed patient in the country, including those receiving care at US Oncology affiliated practices, has easy and immediate access to the information they need throughout their battle with cancer," says Grant Bogle, executive vice president of US Oncology. "Similar to other US Oncology affiliations, the CURE team will have means to resources to expand their services into areas such as electronic distribution and additional content development to help them realize their vision and increase readership."  

With business headquarters remaining in Dallas, CURE plans to continue its existing business while expanding to provide the cancer community with more resources—in print, in person, and online.

CURE will continue to be available to patients, survivors, and professionals free of charge. For subscription information, visit www.curetoday.com.

About CURE Media Group

Through its unique and award-winning products, Dallas-based CURE Media Group has become the source of information and inspiration for those on the cancer journey. CURE Media Group's flagship product, CURE magazine, is the indispensable guide for every stage of the cancer experience.  By combining science and humanity, CURE helps patients, survivors, and caregivers navigate the cancer journey and understand their diagnosis and treatment, while providing tools to cope during and after cancer. Through the magazine, an annual resource guide for the newly diagnosed, educational forums, books, and an interactive website and variety of online tools, CURE Media Group combines science and humanity to make cancer understandable. More information can be found at www.curetoday.com.

About US Oncology

US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system—from drug development to distribution and outcomes measurement—enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,310 physicians operating in 493 locations, including 98 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.

SOURCE CURE Media Group